SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-06-043382
Filing Date
2006-06-23
Accepted
2006-06-23 14:57:08
Documents
7
Period of Report
2006-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-14254_18k.htm 8-K 48586
2 EX-10 a06-14254_1ex10d1.htm EX-10.1 66886
3 EX-10 a06-14254_1ex10d2.htm EX-10.2 69604
4 EX-10 a06-14254_1ex10d3.htm EX-10.3 89527
5 EX-10 a06-14254_1ex10d4.htm EX-10.4 91197
6 EX-99 a06-14254_1ex99d1.htm EX-99.1 10940
7 GRAPHIC g142541kii001.jpg GRAPHIC 2783
  Complete submission text file 0001104659-06-043382.txt   382509
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 06922107
SIC: 2835 In Vitro & In Vivo Diagnostic Substances